Liraglutide has demonstrated efficacy as an add-on therapy for type 2 diabetes mellitus

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1608, 2007-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The glucagon-like peptide-1 analogue liraglutide has demonstrated promising properties for once-daily treatment of type-2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Add-on therapies to metformin for type 2 diabetes

By Shomali Mansur

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 1, 2011-01 ,pp. : 47-62

Informa Healthcare

Access to resources Recommend Favorite

Liraglutide: a guide to its use in type 2 diabetes mellitus

Drugs & Therapy Perspectives, Vol. 26, Iss. 9, 2010-09 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Liraglutide: A Review of its Use in Type 2 Diabetes Mellitus

By Croom Katherine F. McCormack Paul L.

Drugs, Vol. 69, Iss. 14, 2009-10 ,pp. : 1985-2004

Adis International

Access to resources Recommend Favorite

Liraglutide: A Review of its Use in the Management of Type 2 Diabetes Mellitus

By Perry Caroline M.

Drugs, Vol. 71, Iss. 17, 2011-12 ,pp. : 2347-2373

Adis International

Access to resources Recommend Favorite